You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo Nordisk
since
auto-detected in 168 stories
4 days ago
Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap.
9 days ago
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads ⊖
found
Denmark's Novo Nordisk said on Tuesday that it had sued Lilly, arguing consumers were being misled about how the companies' products compare.
12 days ago
Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads ⊖
found
a story from The Guardian ⚠️ › International
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective
Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “…
22 days ago
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss ⊕
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
33 days ago
Medicare will start covering obesity drugs for the first time. Here's what patients should know ⊕
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
37 days ago
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage ⊖
New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.
50 days ago
Drugmakers race to find a place in the next wave of obesity drugs ○
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
52 days ago
Wegovy weight-loss pill approved in UK ⊕
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
54 days ago
AstraZeneca advances weight-loss pill to take aim at obesity leaders ○
found
a story from Financial Times ✅ › Financial Times
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
59 days ago
Revolutionary Wegovy Pill weight-loss drug set to be approved for use in Britain 'within days' - and it will be cheaper than injections ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
The daily tablet, called the Wegovy Pill, is expected to get the greenlight from health officials, according to sources close to the drug's developer, the Danish firm Novo Nordisk.